Contact
Please use this form to send email to PR contact of this press release:
Neothetics Announces Issuance by USPTO of Eighth Patent Directed to LIPO-202 Lead Clinical Asset
TO:
Please use this form to send email to PR contact of this press release:
Neothetics Announces Issuance by USPTO of Eighth Patent Directed to LIPO-202 Lead Clinical Asset
TO: